To further explore the relationship between PTM score and immune therapy sensitivity‐related indicators, we conducted a correlation analysis with metrics such as dysfunction, interferon‐gamma (IFNG), exclusion, microsatellite instability (MSI), and the tumor immune dysfunction and exclusion (TIDE) score. The gene discussed is IFNG; the disease is neoplasm.